Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huangqin total aglycone capsule for NIH type III prostatitis (damp-heat in lower burner) – randomized double-blind placebo-controlled phase II trial
CTR20233926Phase 2Completed
- Sponsor
- China Pharmaceutical University
- Start
- Dec 2023
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of huangqin total aglycone capsule in Prostatodynia (CP/CPPS), sponsored by China Pharmaceutical University. Started Dec 2023; status: completed.
02
Drugs
huangqin total aglycone capsule
03
Conditions
Prostatodynia (CP/CPPS)
Beyond the preview
Go deeper on CTR20233926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233926.